Lupin gets tentative FDA ok for generic eszopiclone
This article was originally published in Scrip
Executive Summary
Lupin Pharmaceuticals, a US subsidiary of Lupin of India, has received tentative US FDA approval for its ANDA for eszopiclone tablets 1mg, 2mg and 3mg, generic versions of Sepracor's insomnia treatment, Lunesta.